I agree that this site is using cookies. You can find further informations here.
X
Laadem, Abderrahmane
33  results:
Search for persons X
?
1

A Phase I, Multicenter, Open-Label, First-in-Human Study of..:

George, Suzanne ; Heinrich, Michael C. ; Somaiah, Neeta...
Clinical Cancer Research.  29 (2023)  18 - p. 3659-3667 , 2023
Link: https://doi.org/10.1158/..
 
?
2

Comparison of demographics, disease characteristics, and ou..:

Lesegretain, Arnaud ; Brunner, Andrew ; King, Andrew J....
Leukemia Research.  125 (2023)  - p. 107006 , 2023
Link: https://doi.org/10.1016/..
 
?
3

MDS-556 Comparison of Demographics, Disease Characteristics..:

Lesegretain, Arnaud ; Laadem, Abderrahmane ; Fell, Geoffrey.
Clinical Lymphoma Myeloma and Leukemia.  22 (2022)  - p. S322 , 2022
Link: https://doi.org/10.1016/..
 
?
4

Poster: MDS-556 Comparison of Demographics, Disease Charact..:

Lesegretain, Arnaud ; Laadem, Abderrahmane ; Fell, Geoffrey.
Clinical Lymphoma Myeloma and Leukemia.  22 (2022)  - p. S154 , 2022
Link: https://doi.org/10.1016/..
 
?
5

MDS-171: Effects of Luspatercept on Serum Ferritin in Patie..:

Fenaux, Pierre ; Santini, Valeria ; Mufti, Ghulam J....
Clinical Lymphoma Myeloma and Leukemia.  20 (2020)  - p. S317 , 2020
Link: https://doi.org/10.1016/..
 
?
6

Population Pharmacokinetics and Exposure–Response of Luspat..:

Chen, Nianhang ; Kassir, Nastya ; Laadem, Abderrahmane...
CPT: Pharmacometrics & Systems Pharmacology.  9 (2020)  7 - p. 395-404 , 2020
Link: https://doi.org/10.1002/..
 
?
7

MDS-175: Assessment of Dose-Dependent Response to Luspaterc..:

Platzbecker, Uwe ; Fenaux, Pierre ; Mufti, Ghulam J....
Clinical Lymphoma Myeloma and Leukemia.  20 (2020)  - p. S318 , 2020
Link: https://doi.org/10.1016/..
 
?
8

MDS-280: Longer-Term RBC Transfusion Reduction in the Phase..:

Komrokji, Rami S. ; Sekeres, Mikkael A. ; Zeidan, Amer M....
Clinical Lymphoma Myeloma and Leukemia.  20 (2020)  - p. S322 , 2020
Link: https://doi.org/10.1016/..
 
?
9

Population Pharmacokinetics and Exposure‐Response Relations..:

Chen, Nianhang ; Kassir, Nastya ; Laadem, Abderrahmane...
The Journal of Clinical Pharmacology.  61 (2020)  1 - p. 52-63 , 2020
Link: https://doi.org/10.1002/..
 
?
10

MDS-191: Long-Term Efficacy and Safety of Luspatercept in L..:

Platzbecker, Uwe ; Kiewe, Philipp ; Germing, Ulrich...
Clinical Lymphoma Myeloma and Leukemia.  20 (2020)  - p. S319-S320 , 2020
Link: https://doi.org/10.1016/..
 
?
11

MDS-179: Clinical Benefit of Luspatercept in Patients with ..:

Zeidan, Amer M. ; Garcia-Manero, Guillermo ; DeZern, Amy E....
Clinical Lymphoma Myeloma and Leukemia.  20 (2020)  - p. S318-S319 , 2020
Link: https://doi.org/10.1016/..
 
?
12

Quality of life in patients with β‐thalassemia: A prospecti..:

Cappellini, Maria Domenica ; Kattamis, Antonis ; Viprakasit, Vip...
American Journal of Hematology.  94 (2019)  10 - p. , 2019
Link: https://doi.org/10.1002/..
 
?
13

Validation of a patient‐reported outcomes symptom measure f..:

Taher, Ali ; Cappellini, Maria Domenica ; Viprakasit, Vip...
American Journal of Hematology.  94 (2018)  2 - p. 177-183 , 2018
Link: https://doi.org/10.1002/..
 
?
14

Development of a patient‐reported outcomes symptom measure ..:

Taher, Ali ; Viprakasit, Vip ; Cappellini, Maria Domenica...
American Journal of Hematology.  94 (2018)  2 - p. 171-176 , 2018
Link: https://doi.org/10.1002/..
 
?
15

Sotatercept (ACE-011) for the treatment of chemotherapy-ind..:

Raftopoulos, Haralambos ; Laadem, Abderrahmane ; Hesketh, Paul J....
Supportive Care in Cancer.  24 (2015)  4 - p. 1517-1525 , 2015
Link: https://doi.org/10.1007/..
 
1-15